Gladstone Land told investors last quarter that it was very hopeful the worst was behind it, pointing to pistachio prices up by two-thirds and almond prices at a decade high. The market has not taken management at its word. Shares have fallen 8.5% since that report, trailing the S&P 500 by more than five percentage points, and now sit near $7.42. That puts the farmland REIT's fiscal third-quarter release, due after the close on November 10, in an awkward spot: the operating story is supposedly improving just as the stock keeps sinking.
On paper, the bar looks easy to clear. Analysts expect earnings of $0.11 per share on revenue of $19.6 million, up from $0.04 and $17.8 million a year ago. That works out to EPS growth of about 175% and revenue growth of roughly 10%. The large percentage gain comes off a very small base, so it says more about how depressed last year's results were than about a major earnings surge. The sequential change matters more. Revenue is expected to rise sharply from $12.7 million in the seasonally weak second quarter, when adjusted results came in at a loss of $0.04 per share. Management did not issue a quantified outlook and declined to give a participation-rent range until yields are known. That leaves consensus resting on management's direction rather than on any figure the company has committed to.
The central question is how much of the nut-price improvement reaches the income statement, and when. Management now expects the 2025 pistachio crop to settle at no less than $2.70 per pound. That implies a bonus near $1.00 per pound, against the $0.50 partial payment already received and the $0.40 to $0.90 range discussed one quarter earlier. The 2026 crop carries a guaranteed initial price of $2.50. The offset is volume. This is an off year for pistachios, and a March heat spell caused blanks, small nuts and enough crop drop that insurance claims are already open. Management itself said the clearest confirmation will come in the fourth quarter, when crop revenue lands. This report is therefore an early read. Commentary on harvest yields, insurance recoveries and the timing of the remaining pistachio bonus may matter as much as the headline EPS figure.
Several smaller items will show whether the recovery is broadening or merely holding. Management expected to sign alternative revenue deals, including solar, cattle, fallowing and water leases, on vacant acreage before the end of this quarter. Evidence that those deals closed would support its argument that idle land can earn its keep. Investors should also look for updates on tenants still on non-accrual status, the pending Arizona farm sale that led to last quarter's impairment, and whether the cyclospora-driven slump in fresh produce demand has hurt berry and leafy-green tenants. On the water side, a late increase in federal allocations should have eased operating costs. Any further asset writedowns or citrus weakness would undercut the idea that problem assets have been contained.
The balance sheet adds a longer-dated test. About $148 million of loans reprice within a year, including a roughly $130 million MetLife facility in January 2027, and the current weighted rate is just 3.45%. Management highlighted about $125 million of available capital and has been buying back preferred stock at a 7.2% yield. Investors will want to know how much higher borrowing costs could eat into the nut-driven gains. With the stock now yielding more than 7.5%, the flat dividend also deserves attention.
Sentiment has improved noticeably, with the bearish reading easing to about 22% from roughly 51% before the last report. The chart tells a gloomier story. The stock trades well below its 200-day average of $9.64, sits just above its post-earnings low of $7.09 and has broken beneath the prior quarter's floor of $7.92. Ultimately, the recovery story holds up only if management can show that higher pistachio and almond prices will more than offset weaker yields, so that participation rent in the fourth quarter rises meaningfully. A clean third quarter without that bridge to year-end cash flow is unlikely to win back a skeptical market.